NCT02593474View on ClinicalTrials.gov

Medication-Assisted Treatment for Youth With Substance Use Disorders

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Opioid Use DisorderOpioid Dependence
Interventions
DRUG

Naltrexone

Outpatient detoxification and induction onto long-acting naltrexone followed by an additional second injection of long-acting naltrexone and and additional third if desired.

Trial Locations (2)

10032

New York State Psychiatric Insitute, New York

New York State Psychiatric Institute, New York

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT02593474 - Medication-Assisted Treatment for Youth With Substance Use Disorders | Biotech Hunter | Biotech Hunter